115 related articles for article (PubMed ID: 10458524)
1. cAMP and in vitro inotropic actions of secretin and VIP in rat papillary muscle.
Rice PJ; Lindsay GW; Bogan CR; Hancock JC
Peptides; 1999; 20(4):519-22. PubMed ID: 10458524
[TBL] [Abstract][Full Text] [Related]
2. Secretin and vasoactive intestinal peptide are potent stimulants of cellular contraction and accumulation of cyclic AMP in rat ventricular cardiomyocytes.
Bell D; McDermott BJ
J Cardiovasc Pharmacol; 1994 Jun; 23(6):959-69. PubMed ID: 7523789
[TBL] [Abstract][Full Text] [Related]
3. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
4. VIP and secretin augment cardiac L-type calcium channel currents in isolated adult rat ventricular myocytes.
Tiaho F; Nerbonne JM
Pflugers Arch; 1996 Sep; 432(5):821-30. PubMed ID: 8772132
[TBL] [Abstract][Full Text] [Related]
5. The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (fa/?) Zucker rats.
Robberecht P; De Neef P; Camus JC; Waelbroeck M; Fontaine J; Christophe J
Pflugers Arch; 1983 Aug; 398(3):217-20. PubMed ID: 6314240
[TBL] [Abstract][Full Text] [Related]
6. Adenylyl cyclase-mediated effects contribute to increased Isoprenaline-induced cardiac contractility in TRPM4-deficient mice.
Uhl S; Mathar I; Vennekens R; Freichel M
J Mol Cell Cardiol; 2014 Sep; 74():307-17. PubMed ID: 24972051
[TBL] [Abstract][Full Text] [Related]
7. Hormone-specific combinations of isoforms of adenylyl cyclase and phosphodiesterase in the rat liver.
Yamatani K; Saito K; Takahashi K; Ohnuma H; Manaka H; Sasaki H
Regul Pept; 2001 May; 99(1):45-52. PubMed ID: 11257314
[TBL] [Abstract][Full Text] [Related]
8. Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat.
Chatelain P; Robberecht P; De Neef P; Camus JC; Poloczek P; Christophe J
Pflugers Arch; 1981 Apr; 390(1):10-6. PubMed ID: 6264381
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
Wessels-Reiker M; Basiboina R; Howlett AC; Strong R
J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740
[TBL] [Abstract][Full Text] [Related]
10. Comparison of inotropic and chronotropic effects of vasoactive intestinal peptide in isolated dog atria.
Wallick DW; Stuesse SL
J Auton Nerv Syst; 1996 Dec; 61(3):257-63. PubMed ID: 8988483
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic modulation by VIP, secretin and isoproterenol of somatostatin release from enriched enteric synaptosomes: role of cAMP.
Kurjak M; Schusdziarra V; Allescher HD
Eur J Pharmacol; 1996 Oct; 314(1-2):165-73. PubMed ID: 8957233
[TBL] [Abstract][Full Text] [Related]
12. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Katano Y; Endoh M
J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
[TBL] [Abstract][Full Text] [Related]
14. Effect of secretin and VIP on isolated pancreatic duct fragments in vitro.
Creutzfeldt W; Foelsch UR
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():59-63. PubMed ID: 6262064
[TBL] [Abstract][Full Text] [Related]
15. Effect of vasoactive intestinal polypeptide (VIP) on cyclic AMP level and relaxation in rat isolated aorta.
Schoeffter P; Stoclet JC
Eur J Pharmacol; 1985 Feb; 109(2):275-9. PubMed ID: 2986998
[TBL] [Abstract][Full Text] [Related]
16. Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria.
Robberecht P; De Neef P; Waelbroeck M; Camus JC; Fontaine J; Christophe J
Pflugers Arch; 1984 May; 401(1):1-5. PubMed ID: 6540864
[TBL] [Abstract][Full Text] [Related]
17. Use of the cyclic AMP antagonist, Rp-cAMPS, to distinguish between cyclic AMP-dependent and cyclic AMP-independent contractile responses in rat ventricular cardiomyocytes.
Bell D; McDermott BJ
J Mol Cell Cardiol; 1994 Nov; 26(11):1439-48. PubMed ID: 7897668
[TBL] [Abstract][Full Text] [Related]
18. Secretin and VIP-stimulated adenylate cyclase from rat heart. I. General properties and structural requirements for enzyme activation.
Chatelain P; Robberecht P; De Neef P; Deschodt-Lanckman M; König W; Christophe J
Pflugers Arch; 1980 Dec; 389(1):21-7. PubMed ID: 7193463
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury.
Mohney RP; Zigmond RE
J Neurosci; 1998 Jul; 18(14):5285-93. PubMed ID: 9651211
[TBL] [Abstract][Full Text] [Related]
20. Regulation of tyrosine hydroxylase activity in rat PC12 cells by neuropeptides of the secretin family.
Roskoski R; White L; Knowlton R; Roskoski LM
Mol Pharmacol; 1989 Dec; 36(6):925-31. PubMed ID: 2574821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
